ABEO logo

Abeona Therapeutics (ABEO) Return On Assets

Annual ROA

-84.53%
-29.32%-53.11%

December 31, 2023


Summary


Performance

ABEO ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABEOprofitabilitymetrics:

Quarterly ROA

-72.22%
-10.14%-16.33%

September 30, 2024


Summary


Performance

ABEO Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherABEOprofitabilitymetrics:

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

ABEO ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-53.1%+21.0%
3 y3 years-87.9%-87.4%
5 y5 years-163.4%-50.0%

ABEO ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-53.1%at low-38.3%+39.1%
5 y5-year-120.4%at low-119.5%+39.1%
alltimeall time-122.3%+86.0%-104.7%+97.5%

Abeona Therapeutics ROA History

DateAnnualQuarterly
Sep 2024
-
-72.22%(+16.3%)
Jun 2024
-
-62.08%(-47.7%)
Mar 2024
-
-118.64%(+29.7%)
Dec 2023
-84.53%(+53.1%)
-91.46%(+21.3%)
Sep 2023
-
-75.41%(-2.3%)
Jun 2023
-
-77.21%(+47.9%)
Mar 2023
-
-52.22%(-25.7%)
Dec 2022
-55.21%(-25.0%)
-70.27%(-40.2%)
Sep 2022
-
-117.50%(+26.3%)
Jun 2022
-
-93.05%(+7.6%)
Mar 2022
-
-86.50%(+26.7%)
Dec 2021
-73.61%(+63.7%)
-68.29%(+77.2%)
Sep 2021
-
-38.54%(+6.1%)
Jun 2021
-
-36.33%(+10.4%)
Mar 2021
-
-32.90%(-31.8%)
Dec 2020
-44.98%(+17.3%)
-48.23%(-1.7%)
Sep 2020
-
-49.04%(-10.7%)
Jun 2020
-
-54.90%(-10.1%)
Mar 2020
-
-61.09%(+38.7%)
Dec 2019
-38.35%(+19.5%)
-44.04%(-8.5%)
Sep 2019
-
-48.13%(+4.2%)
Jun 2019
-
-46.17%(+20.4%)
Mar 2019
-
-38.35%(+15.9%)
Dec 2018
-32.09%(+70.2%)
-33.10%(+8.0%)
Sep 2018
-
-30.64%(+19.6%)
Jun 2018
-
-25.62%(+2.5%)
Mar 2018
-
-25.00%(+7.5%)
Dec 2017
-18.85%(-17.6%)
-23.25%(-13.3%)
Sep 2017
-
-26.81%(+6.8%)
Jun 2017
-
-25.11%(+2.8%)
Mar 2017
-
-24.42%(-7.0%)
Dec 2016
-22.89%(-23.9%)
-26.26%(+20.5%)
Sep 2016
-
-21.79%(-16.0%)
Jun 2016
-
-25.95%(-3.2%)
Mar 2016
-
-26.80%(+1.9%)
Dec 2015
-30.06%(-90.3%)
-26.29%(-57.2%)
Sep 2015
-
-61.41%(-32.6%)
Jun 2015
-
-91.12%(-80.0%)
Mar 2015
-
-454.75%(-38.2%)
Dec 2014
-311.46%(-182.0%)
-735.94%(-75.0%)
Sep 2014
-
-2943.03%(+94.3%)
Jun 2014
-
-1514.32%(+3786.9%)
Mar 2014
-
-38.96%(-113.2%)
Dec 2013
379.77%(-199.4%)
294.52%(-81.0%)
Sep 2013
-
1550.71%(+177.4%)
Jun 2013
-
558.93%(-839.8%)
Mar 2013
-
-75.55%(-82.2%)
Dec 2012
-381.94%(+847.0%)
-425.29%(-63.6%)
Sep 2012
-
-1168.35%(+162.6%)
Jun 2012
-
-444.86%(+240.5%)
Mar 2012
-
-130.66%(+175.7%)
Dec 2011
-40.33%
-47.39%(+368.7%)
Sep 2011
-
-10.11%(-96.0%)
DateAnnualQuarterly
Jun 2011
-
-255.09%(+29.6%)
Mar 2011
-
-196.76%(+12.0%)
Dec 2010
-145.59%(-75.8%)
-175.66%(-71.3%)
Sep 2010
-
-611.30%(+86.0%)
Jun 2010
-
-328.74%(-28.2%)
Mar 2010
-
-458.08%(-23.7%)
Dec 2009
-602.71%(+27.7%)
-600.67%(+113.6%)
Sep 2009
-
-281.21%(+23.2%)
Jun 2009
-
-228.18%(+21.5%)
Mar 2009
-
-187.79%(-33.9%)
Dec 2008
-471.94%(+69.0%)
-284.22%(-38.9%)
Sep 2008
-
-465.34%(+0.3%)
Jun 2008
-
-463.85%(-6.2%)
Mar 2008
-
-494.76%(+25.5%)
Dec 2007
-279.22%(+47.9%)
-394.13%(+85.1%)
Sep 2007
-
-212.96%(+18.0%)
Jun 2007
-
-180.46%(+10.6%)
Mar 2007
-
-163.22%(+0.3%)
Dec 2006
-188.78%(+916.0%)
-162.79%(+268.7%)
Sep 2006
-
-44.15%(+3.9%)
Jun 2006
-
-42.51%(-4.0%)
Mar 2006
-
-44.28%(+145.3%)
Dec 2005
-18.58%(-79.2%)
-18.05%(-82.7%)
Sep 2005
-
-104.51%(+11.3%)
Jun 2005
-
-93.90%(+28.9%)
Mar 2005
-
-72.85%(+0.8%)
Dec 2004
-89.41%(+101.7%)
-72.24%(+5.5%)
Sep 2004
-
-68.45%(+6.0%)
Jun 2004
-
-64.55%(+43.5%)
Mar 2004
-
-44.98%(+0.4%)
Dec 2003
-44.32%(+6.2%)
-44.79%(+15.3%)
Sep 2003
-
-38.85%(+1.6%)
Jun 2003
-
-38.25%(-19.7%)
Mar 2003
-
-47.66%(+14.7%)
Dec 2002
-41.73%(+93.9%)
-41.56%(+15.5%)
Sep 2002
-
-35.98%(+22.3%)
Jun 2002
-
-29.43%(+17.4%)
Mar 2002
-
-25.07%(+16.1%)
Dec 2001
-21.52%(-30.4%)
-21.59%(+4.5%)
Sep 2001
-
-20.67%(+0.9%)
Jun 2001
-
-20.49%(-5.8%)
Mar 2001
-
-21.75%(-18.1%)
Dec 2000
-30.91%(-67.3%)
-26.56%(-13.7%)
Sep 2000
-
-30.79%(-30.7%)
Jun 2000
-
-44.43%(-23.1%)
Mar 2000
-
-57.80%(-44.0%)
Dec 1999
-94.51%(-46.5%)
-103.30%(+17.8%)
Sep 1999
-
-87.71%(-26.7%)
Jun 1999
-
-119.63%(+155.2%)
Mar 1999
-
-46.87%
Dec 1998
-176.76%(+26.9%)
-
Dec 1997
-139.33%(-57.1%)
-
Dec 1996
-324.84%(-2127.7%)
-
Dec 1995
16.02%
-

FAQ

  • What is Abeona Therapeutics annual return on assets?
  • What is the all time high annual ROA for Abeona Therapeutics?
  • What is Abeona Therapeutics annual ROA year-on-year change?
  • What is Abeona Therapeutics quarterly return on assets?
  • What is the all time high quarterly ROA for Abeona Therapeutics?
  • What is Abeona Therapeutics quarterly ROA year-on-year change?

What is Abeona Therapeutics annual return on assets?

The current annual ROA of ABEO is -84.53%

What is the all time high annual ROA for Abeona Therapeutics?

Abeona Therapeutics all-time high annual return on assets is 379.77%

What is Abeona Therapeutics annual ROA year-on-year change?

Over the past year, ABEO annual return on assets has changed by -29.32% (-53.11%)

What is Abeona Therapeutics quarterly return on assets?

The current quarterly ROA of ABEO is -72.22%

What is the all time high quarterly ROA for Abeona Therapeutics?

Abeona Therapeutics all-time high quarterly return on assets is 1550.71%

What is Abeona Therapeutics quarterly ROA year-on-year change?

Over the past year, ABEO quarterly return on assets has changed by +19.24% (+21.04%)